Sven Zimmermann

Sven Zimmermann is the current CEO at Inotrem. Prior to this, they served as the Chief Financial Officer at MetrioPharm from August 2019 to March 2021. Sven has also held CFO positions at Nanolive SA, PregLem, and Novimmune SA. In addition, Zimmermann served as the Chairman of the Board at Aimago SA and as a Board Member at Epiontis GmbH. Prior to their work in the private sector, Zimmermann worked as an equity analyst at UBS from January 2001 to December 2008.

Some direct reports include Jean-Jacques Garaud - EVP, Head of Scientific and Medical Affairs, Margarita Salcedo Magguilli - Chief Development officer, and Jason R. Dinges - Director.